VVZ API is not affiliated with ETH Zurich. Data might be outdated or incorrect. Please view the official ETHZ Vorlesungsverzeichnis for binding information.

535-0030-00L 3 Credits MSC , WBZ D-CHAB
You're viewing possible stale or outdated data. Please check the latest semester for more up-to-date information.

Pharmaceutical Immunology II & Therapeutic Proteins

Prerequisites: Either 535-0830-00L Pharmaceutical Immunology I or 551-0317-00L Immunology I must have been taken.
VVZ CR n/a

Last Updated: 2026-06-01 11:30:39

Abstract

In this course, various topics related to the development, GMP production and application of therapeutic proteins will be discussed. Furthermore, students will expand their training in pharmaceutical immunology and will be introduced to the basic concepts of pharmaceutical product quality management.

Objective

Students know and understand: - basic mechanisms and regulation of the immune response - the pathogenic mechanisms of the most important immune-mediated disorders - the concepts of vaccination and cancer immunotherapy - the most frequently used expression systems for the production of therapeutic proteins - the use of protein engineering tools for modifying different features of therapeutic proteins - the mechanism of action of selected therapeutic proteins and their application - basic concepts in the GMP production of therapeutic proteins

Content

The course consists of two parts: In the first part, students will complete their training in Pharmaceutical Immunology. This part particularly focuses on the pathogenic mechanisms of immune-mediated diseases, vaccination and cancer immunotherapy. Deepened knowledge of immunology will be relevant for understanding the mechanism of action of many therapeutic proteins, as well as for understanding one major concern related to the use of protein-based drugs, namely, immunogenicity. The second part focuses on topics related to the development and application of therapeutic proteins, such as protein expression, protein engineering, reducing immunogenicity, and GMP production of therapeutic proteins. Furthermore, selected examples of approved therapeutic proteins will be discussed.

Resources

Lecture Notes

Handouts to the lectures will be available for downloading underhttp://www.pharma.ethz.ch/scripts/index

Literature

- Janeway's ImmunoBiology, by Kenneth Murphy (9th or 10th Edition) - Lecture Handouts - Paper References provided in the Scripts - EMEA Dossier for Humira

General Information

Language
English
Levels
MSC , WBZ
Frequency
Yearly recurring

Examination

Type
session examination
Mode
oral 15 minutes

Registration & Places

Priority: Registration for the course unit is only possible for the primary target group

Course Components

Type Title Time & Place Hours
lecture with exercise Pharmaceutical Immunology II & Therapeutic Proteins
  • Mon 09:45-12:30 (HIL E 9)
3 h weekly

Offered In